ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 285,86
-0,60%
Dow Jones
39 142,23
-1,33%
DAX
21 205,86
-0,52%
Brent Oil
67,075
0,00%
Bitcoin
84 960,35
0,05%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Solid Biosciences Inc (SLDB)

  7. Solid Biosciences Inc (SLDB) Actualités

SLDB

Solid Biosciences (SLDB)

Solid Biosciences Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:SLDB
DateHeureSourceTitreSymboleSociété
18/04/202500h50Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:SLDBSolid Biosciences Inc
11/04/202523h03Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SLDBSolid Biosciences Inc
07/04/202514h00GlobeNewswire Inc.Solid Biosciences to Participate at Upcoming Investor ConferencesNASDAQ:SLDBSolid Biosciences Inc
01/04/202514h00GlobeNewswire Inc.Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:SLDBSolid Biosciences Inc
01/04/202513h00GlobeNewswire Inc.Climb Bio Appoints Seasoned Biotech Leaders to Board of DirectorsNASDAQ:SLDBSolid Biosciences Inc
17/03/202505h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SLDBSolid Biosciences Inc
13/03/202521h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SLDBSolid Biosciences Inc
12/03/202513h00GlobeNewswire Inc.Solid Biosciences to Present at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific ConferenceNASDAQ:SLDBSolid Biosciences Inc
06/03/202523h01Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:SLDBSolid Biosciences Inc
06/03/202522h35Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SLDBSolid Biosciences Inc
06/03/202522h16GlobeNewswire Inc.Solid Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdatesNASDAQ:SLDBSolid Biosciences Inc
25/02/202522h05Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:SLDBSolid Biosciences Inc
22/02/202500h04Edgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:SLDBSolid Biosciences Inc
18/02/202522h52Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SLDBSolid Biosciences Inc
18/02/202522h47Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SLDBSolid Biosciences Inc
18/02/202522h35Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNASDAQ:SLDBSolid Biosciences Inc
18/02/202513h00GlobeNewswire Inc.Solid Biosciences Announces Pricing of Underwritten OfferingNASDAQ:SLDBSolid Biosciences Inc
18/02/202512h45GlobeNewswire Inc.Solid Biosciences Reports Positive Initial Clinical Data from Next-Generation Duchenne Gene Therapy Candidate SGT-003NASDAQ:SLDBSolid Biosciences Inc
14/02/202523h25Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SLDBSolid Biosciences Inc
21/01/202514h30GlobeNewswire Inc.Solid Biosciences Receives FDA Fast Track Designation for SGT-212 Dual Route of Administration Gene Therapy for Friedreich’s AtaxiaNASDAQ:SLDBSolid Biosciences Inc
15/01/202522h05GlobeNewswire Inc.Solid Biosciences Outlines Key Priorities for Advancing Diversified Neuromuscular and Cardiac Development Pipeline and Establishing Leadership in Precision Genetic MedicinesNASDAQ:SLDBSolid Biosciences Inc
08/01/202522h05GlobeNewswire Inc.Solid Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:SLDBSolid Biosciences Inc
07/01/202522h15GlobeNewswire Inc.Solid Biosciences Announces FDA IND Clearance for First-In-Industry Dual Route of Administration Gene Therapy to Treat Both Neurologic and Cardiac Manifestations of Friedreich’s AtaxiaNASDAQ:SLDBSolid Biosciences Inc
23/12/202422h05GlobeNewswire Inc.Solid Biosciences Added to the Nasdaq Biotechnology IndexNASDAQ:SLDBSolid Biosciences Inc
04/12/202414h00GlobeNewswire Inc.Solid Biosciences Announces Collaboration with Mayo Clinic to Accelerate Gene Therapy Innovation and Advance Development of Cardiac Gene TherapiesNASDAQ:SLDBSolid Biosciences Inc
14/11/202418h02Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:SLDBSolid Biosciences Inc
14/11/202414h00GlobeNewswire Inc.Solid Biosciences to Present at the Jefferies London Healthcare ConferenceNASDAQ:SLDBSolid Biosciences Inc
12/11/202422h58Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:SLDBSolid Biosciences Inc
06/11/202422h05GlobeNewswire Inc.Solid Biosciences Reports Third Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:SLDBSolid Biosciences Inc
06/11/202422h02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SLDBSolid Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:SLDB

Dernières Valeurs Consultées

EU
BNP
BNP Paribas
FTSE
UKX
FTSE 100
NASDAQ
AMZN
Amazon.com
EU
LR
Legrand
EU
EN
Bouygues
COIN
BTCUSD
Bitcoin
EU
HO
Thales
EU
BEL20
Bel 20
EU
SGO
Cie de SaintGobain
EU
ACA
Credit Agricole
EU
PX1
CAC 40
NYSE
KO
Coca Cola
NYSE
JPM
JP Morgan Chase
NASDAQ
GOOGL
Alphabet
COIN
DOGEUSD
Dogecoin
Delayed Upgrade Clock
ADVFN Logo
France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces